NewslettersPancreatic Cell NewsFDA Grants Orphan Drug Designation to PYX-201 in Pancreatic CancerBy Bob - May 16, 20230268The FDA has granted an orphan drug designation for PYX-201 to continue its development as a treatment for patients with pancreatic cancer.[Pyxis Oncology, Inc. (Targeted Oncology)]Press Release